Literature DB >> 22366654

2-Amidino analogs of glycine-amiloride conjugates: inhibitors of urokinase-type plasminogen activator.

Archna P Massey1, William R Harley, NagaRekha Pasupuleti, Fredric A Gorin, Michael H Nantz.   

Abstract

The relative non-toxicity of the diuretic amiloride, coupled with its selective inhibition of the protease urokinase plasminogen activator (uPA), makes this compound class attractive for structure-activity studies. Herein we substituted the C(2)-acylguanidine of C(5)-glycyl-amiloride with amidine and amidoxime groups. The data show the importance of maintaining C(5)-hydrophobicity. The C(5)-benzylglycine analogs containing either C(2)-acylguanidine or amidine inhibited uPA with an IC(50) ranging from 3 to 7 μM and were cytotoxic to human U87 malignant glioma cells.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366654      PMCID: PMC3329872          DOI: 10.1016/j.bmcl.2011.12.123

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  18 in total

1.  Re-engineering of human urokinase provides a system for structure-based drug design at high resolution and reveals a novel structural subsite.

Authors:  V Nienaber; J Wang; D Davidson; J Henkin
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

2.  Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite.

Authors:  V L Nienaber; D Davidson; R Edalji; V L Giranda; V Klinghofer; J Henkin; P Magdalinos; R Mantei; S Merrick; J M Severin; R A Smith; K Stewart; K Walter; J Wang; M Wendt; M Weitzberg; X Zhao; T Rockway
Journal:  Structure       Date:  2000-05-15       Impact factor: 5.006

3.  (4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase.

Authors:  S Sperl; U Jacob; N Arroyo de Prada; J Stürzebecher; O G Wilhelm; W Bode; V Magdolen; R Huber; L Moroder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Exploiting subsite S1 of trypsin-like serine proteases for selectivity: potent and selective inhibitors of urokinase-type plasminogen activator.

Authors:  R L Mackman; B A Katz; J G Breitenbucher; H C Hui; E Verner; C Luong; L Liu; P A Sprengeler
Journal:  J Med Chem       Date:  2001-11-08       Impact factor: 7.446

Review 5.  Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours.

Authors:  B Muehlenweg; S Sperl; V Magdolen; M Schmitt; N Harbeck
Journal:  Expert Opin Biol Ther       Date:  2001-07       Impact factor: 4.388

6.  Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas.

Authors:  William Harley; Candace Floyd; Tamara Dunn; Xiao-Dong Zhang; Tsung-Yu Chen; Manu Hegde; Hasan Palandoken; Michael H Nantz; Leonardo Leon; K L Carraway; Bruce Lyeth; Fredric A Gorin
Journal:  Brain Res       Date:  2010-10-13       Impact factor: 3.252

7.  Acid-sensing ion channels in malignant gliomas.

Authors:  Bakhrom K Berdiev; Jiazeng Xia; Lee Anne McLean; James M Markert; G Yancey Gillespie; Timothy B Mapstone; Anjaparavanda P Naren; Biljana Jovov; James K Bubien; Hong-Long Ji; Catherine M Fuller; Kevin L Kirk; Dale J Benos
Journal:  J Biol Chem       Date:  2003-02-12       Impact factor: 5.157

8.  Amiloride kills malignant glioma cells independent of its inhibition of the sodium-hydrogen exchanger.

Authors:  Manu Hegde; Jane Roscoe; Peter Cala; Fredric Gorin
Journal:  J Pharmacol Exp Ther       Date:  2004-03-09       Impact factor: 4.030

9.  Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution.

Authors:  Michael D Wendt; Todd W Rockway; Andrew Geyer; William McClellan; Moshe Weitzberg; Xumiao Zhao; Robert Mantei; Vicki L Nienaber; Kent Stewart; Vered Klinghofer; Vincent L Giranda
Journal:  J Med Chem       Date:  2004-01-15       Impact factor: 7.446

10.  Cytostatic potential of novel agents that inhibit the regulation of intracellular pH.

Authors:  P Wong; H-W Kleemann; I F Tannock
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

View more
  6 in total

1.  Mis-trafficking of endosomal urokinase proteins triggers drug-induced glioma nonapoptotic cell death.

Authors:  Nagarekha Pasupuleti; Ana Cristina Grodzki; Fredric Gorin
Journal:  Mol Pharmacol       Date:  2015-01-29       Impact factor: 4.436

2.  Small molecule-RNA targeting: starting with the fundamentals.

Authors:  Amanda E Hargrove
Journal:  Chem Commun (Camb)       Date:  2020-11-26       Impact factor: 6.222

3.  5-Benzylglycinyl-amiloride kills proliferating and nonproliferating malignant glioma cells through caspase-independent necroptosis mediated by apoptosis-inducing factor.

Authors:  Nagarekha Pasupuleti; Leonardo Leon; Kermit L Carraway; Fredric Gorin
Journal:  J Pharmacol Exp Ther       Date:  2012-12-14       Impact factor: 4.030

4.  Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR.

Authors:  Neeraj N Patwardhan; Laura R Ganser; Gary J Kapral; Christopher S Eubanks; Janghyun Lee; Bharathwaj Sathyamoorthy; Hashim M Al-Hashimi; Amanda E Hargrove
Journal:  Medchemcomm       Date:  2017-03-15       Impact factor: 3.597

5.  A cell-permeant amiloride derivative induces caspase-independent, AIF-mediated programmed necrotic death of breast cancer cells.

Authors:  Leonardo J Leon; Nagarekha Pasupuleti; Fredric Gorin; Kermit L Carraway
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

6.  High-Resolution Mass Spectrometry-Based Approaches for the Detection and Quantification of Peptidase Activity in Plasma.

Authors:  Elisa Maffioli; Zhenze Jiang; Simona Nonnis; Armando Negri; Valentina Romeo; Christopher B Lietz; Vivian Hook; Giuseppe Ristagno; Giuseppe Baselli; Erik B Kistler; Federico Aletti; Anthony J O'Donoghue; Gabriella Tedeschi
Journal:  Molecules       Date:  2020-09-06       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.